Excessive IL-1 production leads to pathological inflammation in autoimmune and autoinflammatory diseases such as rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis (sJIA), and cryopyrin-associated periodic syndromes (CAPS) [2,3,4]. Here, IL1B is linked to rheumatoid arthritis.